Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Melatonin–Sacchachitin Hydrogel for Atopic Dermatitis
2026-09-28
Lin et al. developed a melatonin-loaded sacchachitin nanofiber hydrogel and evaluated it as a non-steroidal topical platform in a DNCB-induced NC/Nga mouse model of atopic dermatitis. The formulation reduced disease severity, epidermal hyperplasia, mast cell infiltration, and Th2-associated markers while retaining melatonin stability and the hydrogel’s mechanical and adhesive properties.
-
ABT-737: A BCL-2 Protein Inhibitor for Cancer Research
2026-09-28
ABT-737 is a BH3 mimetic BCL-2 protein inhibitor used to study mitochondrial apoptosis in cancer models. Product information reports activity across several anti-apoptotic BCL-2 family targets, while also leaving important assay and model details unspecified.
-
Fangchinoline Restores Lysosomal Defense Against H1N1
2026-09-27
Cheng and colleagues identify fangchinoline as a lysosome-accumulating compound that activates TFEB, restores lysosomal gene expression, and inhibits H1N1 infection, particularly during viral entry. The findings support lysosome-directed host responses as a research strategy while leaving important questions about dosing, mechanism separation, and translational relevance open.
-
Neuritin Limits ER Stress–Linked Injury After SAH
2026-09-26
The study links endoplasmic-reticulum-stress-associated NF-κB signaling to neuroinflammation and neuronal apoptosis during early brain injury after subarachnoid hemorrhage. It reports that neuritin overexpression suppresses three ER stress-related signaling routes, supporting a mechanistic framework for studying neuroprotection while leaving important questions about pathway specificity and clinical translation.
-
Moesin as a Biomarker of Endothelial Injury in Sepsis
2026-09-25
This study evaluates moesin (MSN) as a circulating indicator of endothelial injury in sepsis and connects its elevation with ROCK1/MLC and NF-κB signaling. Human observations, mouse models, and endothelial-cell experiments provide converging evidence, while leaving clinical diagnostic performance and causality in patients to be established.
-
DiscoveryProbe™: Designing Better Stem Cell Screens
2026-09-25
DiscoveryProbe Stem Cell Compound Library Plus can help researchers move beyond hit lists to interpretable stem cell pathway profiles. This guide focuses on assay design, evidence strength, and the limits of translating a parasite neoblast screen into other stem cell systems.
-
Quercetin Beyond PI3K: Interpreting Ferroptosis Evidence
2026-09-24
Quercetin is often studied as a PI3K inhibitor, but Wilson’s disease models reveal a distinct research angle: testing how ferroptosis, lipid remodeling, and target engagement fit together. This article turns that evidence into practical assay-selection guidance while distinguishing preclinical findings from established therapeutic claims.
-
SFRP1, Neutrophils, and Wnt Signaling in Oral Fibrosis
2026-09-24
An arecoline-induced model study links reduced SFRP1 with increased neutrophil infiltration, Wnt/β-catenin pathway activity, and oral submucous fibrosis. SFRP1 overexpression attenuated inflammatory and fibrotic features, while pathway activation counteracted these effects, supporting a mechanistic connection that warrants further testing.
-
Protease Inhibitor Cocktail EDTA-Free for Biomarkers
2026-09-24
Learn how a Protease Inhibitor Cocktail EDTA-Free can help preserve protein readouts in therapeutic biomarker studies. This article connects a recent melatonin-hydrogel study to practical sample-preparation decisions while clarifying what protease inhibitors can—and cannot—tell you.
-
5X Protein Loading Buffer (Reducing) Guide
2026-09-23
5X Protein Loading Buffer (Reducing) standardizes reducing protein sample preparation for conventional SDS-PAGE by combining SDS, a sulfhydryl reducing agent, buffer salts, and tracking dye. It is intended for denaturing molecular-weight separation and should not be used when native structure, disulfide-dependent complexes, or non-reducing conditions must be preserved.
-
Naked Mole-Rat cGAS Rewrites DNA Repair and Aging
2026-09-22
A 2025 Science study identifies an evolutionary reversal in naked mole-rat cGAS: four amino acid substitutions convert it from a suppressor of homologous recombination into a promoter of DNA repair. The work connects altered cGAS ubiquitination, prolonged chromatin retention, FANCI–RAD50 recruitment, reduced senescence, and improved aging phenotypes across cellular and animal models.
-
BCA Protein Quantification Kit K4102
2026-09-22
The Bicinchoninic Acid Assay (BCA) Protein Quantification Kit K4102 supports low-concentration total protein measurement in samples such as dilute biochemical preparations and cell lysates. It is intended for research workflows, including sample normalization, and must not be used for diagnostic, clinical, or medical testing.
-
U0126-EtOH: MEK1/2 Strategy for Translation
2026-09-21
A mechanistic and translational framework for using U0126-EtOH to dissect MEK1/2–ERK1/2 signaling across neuronal injury, inflammation, and differentiation models while avoiding overinterpretation of pathway-selective data.
-
CHIR-99021 and the Next Generation of Human Neuron Models
2026-09-21
CHIR-99021 (CT99021) offers a mechanistically precise way to tune GSK-3 and Wnt/β-catenin biology in stem-cell workflows. This thought-leadership analysis connects that capability to the qualification of human iPSC-derived sensory neurons for studying HSV-1 latency, while separating validated evidence from forward-looking experimental strategy.
-
Novel PRRSV-1 GD2022: Genome and Pathogenicity
2026-09-20
A 2024 Frontiers in Microbiology study isolated GD2022, a distinct PRRSV-1 subtype 1 strain from southern China, and combined cell culture, molecular, genomic, and animal evidence to characterize it. The findings establish GD2022 as a pathogenic reference isolate while highlighting genomic divergence in antigenic regions and the need for orthogonal confirmation in PRRSV surveillance.